Fragile X premutation RNA is sufficient to cause primary ovarian insufficiency in mice

Human Molecular Genetics

Volumn 21, Issue 23, 2012, Pages 5039-5047

  Lu, Cuiling ^a   Lin, Li ^b   Tan, Huiping ^b   Wu, Hao ^c   Sherman, Stephanie L ^b   Gao, Fei ^a   Jin, Peng ^b   Chen, Dahua ^a  

^a INSTITUTE OF ZOOLOGY   (China)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; FOLLITROPIN; FRAGILE X MENTAL RETARDATION PROTEIN; LUTEINIZING HORMONE; MAMMALIAN TARGET OF RAPAMYCIN; MESSENGER RNA; PROTEIN KINASE B; RNA; RNA BINDING PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY SIZE; CONTROLLED STUDY; EARLY MENOPAUSE; ESTRADIOL BLOOD LEVEL; FEMALE; FEMALE FERTILITY; FOLLITROPIN BLOOD LEVEL; GENE MUTATION; IMMUNOHISTOCHEMISTRY; LUTEINIZING HORMONE BLOOD LEVEL; MOUSE; NONHUMAN; OVARY FOLLICLE DEVELOPMENT; PREMATURE OVARIAN FAILURE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; UTERUS WEIGHT; X CHROMOSOME LINKAGE;

5' UNTRANSLATED REGIONS; ALLELES; ANIMALS; APOPTOSIS; DISEASE MODELS, ANIMAL; FEMALE; FERTILITY; FRAGILE X MENTAL RETARDATION PROTEIN; FRAGILE X SYNDROME; GONADAL HORMONES; HUMANS; MICE; MICE, TRANSGENIC; OVARIAN FOLLICLE; OVARY; OVULATION; PHOSPHORYLATION; PRIMARY OVARIAN INSUFFICIENCY; PROTO-ONCOGENE PROTEINS C-AKT; RNA; TOR SERINE-THREONINE KINASES; TRINUCLEOTIDE REPEAT EXPANSION;

MUS;

EID: 84869025102     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/dds348     Document Type: Article

References (36)

1. Nelson, L.M. (2009) Clinical practice. Primary ovarian insufficiency. N. Engl. J. Med., 360, 606-614.
2. Gallagher, J.C. (2007) Effect of early menopause on bone mineral density and fractures. Menopause, 14, 567-571.
3. Jacobsen, B.K., Knutsen, S.F. and Fraser, G.E. (1999) Age at natural menopause and total mortality and mortality from ischemic heart disease: the Adventist Health Study. J. Clin. Epidemiol., 52, 303-307.
4. Mondul, A.M., Rodriguez, C., Jacobs, E.J. and Calle, E.E. (2005) Age at natural menopause and cause-specific mortality. Am. J. Epidemiol., 162, 1089-1097.
5. Popat, V.B., Calis, K.A., Vanderhoof, V.H., Cizza, G., Reynolds, J.C., Sebring, N., Troendle, J.F. and Nelson, L.M. (2009) Bone mineral density in estrogen-deficient young women. J. Clin. Endocrinol. Metab., 94, 2277-2283.
6. Lohff, J.C., Christian, P.J., Marion, S.L., Arrandale, A. and Hoyer, P.B. (2005) Characterization of cyclicity and hormonal profile with impending ovarian failure in a novel chemical-induced mouse model of perimenopause. Comp. Med., 55, 523-527.
7. Fu, Y.H., Kuhl, D.P., Pizzuti, A., Pieretti, M., Sutcliffe, J.S., Richards, S., Verkerk, A.J., Holden, J.J., Fenwick, R.G. Jr, Warren, S.T. et al. (1991) Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox. Cell, 67, 1047-1058.
8. Kenneson, A., Zhang, F., Hagedorn, C.H. and Warren, S.T. (2001) Reduced FMRP and increased FMR1 transcription is proportionally associated with CGG repeat number in intermediate-length and premutation carriers. Hum. Mol. Genet., 10, 1449-1454.
9. Kremer, E.J., Pritchard, M., Lynch, M., Yu, S., Holman, K., Baker, E., Warren, S.T., Schlessinger, D., Sutherland, G.R. and Richards, R.I. (1991) Mapping of DNA instability at the fragile X to a trinucleotide repeat sequence p(CCG)n. Science, 252, 1711-1714.
10. Oberle, I., Rousseau, F., Heitz, D., Kretz, C., Devys, D., Hanauer, A., Boue, J., Bertheas, M.F. and Mandel, J.L. (1991) Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome. Science, 252, 1097-1102.
11. Pieretti, M., Zhang, F.P., Fu, Y.H., Warren, S.T., Oostra, B.A., Caskey, C.T. and Nelson, D.L. (1991) Absence of expression of the FMR-1 gene in fragile X syndrome. Cell, 66, 817-822.
12. Verkerk, A.J., Pieretti, M., Sutcliffe, J.S., Fu, Y.H., Kuhl, D.P., Pizzuti, A., Reiner, O., Richards, S., Victoria, M.F., Zhang, F.P. et al. (1991) Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell, 65, 905-914.
13. Sherman, S. (2002). In Hagerman, R.J. (ed.), Fragile X Syndrome: Diagnosis, Treatment and Research. The Johns Hopkins University Press, Baltimore, MD, pp. 136-168.
14. Sullivan, S.D., Welt, C. and Sherman, S. (2011) FMR1 and the continuum of primary ovarian insufficiency. Sem. Reprod. Med., 29, 299-307.
15. Sherman, S.L. (2000) Premature ovarian failure among fragile X premutation carriers: parent-of-origin effect? [comment] [editorial]. Am. J. Hum. Genet., 67, 11-13.
16. Allingham-Hawkins, D.J., Babul-Hirji, R., Chitayat, D., Holden, J.J., Yang, K.T., Lee, C., Hudson, R., Gorwill, H., Nolin, S.L., Glicksman, A. et al. (1999) Fragile X premutation is a significant risk factor for premature ovarian failure: the International Collaborative POF in Fragile X study-preliminary data. Am. J. Med. Genet., 83, 322-325.
17. Sullivan, A.K., Marcus, M., Epstein, M.P., Allen, E.G., Anido, A.E., Paquin, J.J., Yadav-Shah, M. and Sherman, S.L. (2005) Association of FMR1 repeat size with ovarian dysfunction. Hum. Reprod., 20, 402-412.
18. Murray, A., Ennis, S., MacSwiney, F., Webb, J. and Morton, N.E. (2000) Reproductive and menstrual history of females with fragile X expansions. Eur. J. Hum. Genet., 8, 247-252.
19. Hagerman, R.J. and Hagerman, P.J. (2002) The fragile X premutation: into the phenotypic fold. Curr. Opin. Genet. Dev., 12, 278-283.
20. Feng, Y., Zhang, F., Lokey, L.K., Chastain, J.L., Lakkis, L., Eberhart, D. and Warren, S.T. (1995) Translational suppression by trinucleotide repeat expansion at FMR1. Science, 268, 731-734.
21. Tassone, F., Hagerman, R.J., Taylor, A.K., Gane, L.W., Godfrey, T.E. and Hagerman, P.J. (2000) Elevated levels of FMR1 mRNA in carrier males: a new mechanism of involvement in the fragile-X syndrome. Am. J. Hum. Genet., 66, 6-15.
22. Jin, P., Zarnescu, D.C., Zhang, F., Pearson, C.E., Lucchesi, J.C., Moses, K. and Warren, S.T. (2003) RNA-mediated neurodegeneration caused by the fragile X premutation rCGG repeats in Drosophila. Neuron, 39, 739-747.
23. Willemsen, R., Hoogeveen-Westerveld, M., Reis, S., Holstege, J., Severijnen, L.A., Nieuwenhuizen, I.M., Schrier, M., van Unen, L., Tassone, F., Hoogeveen, A.T. et al. (2003) The FMR1 CGG repeat mouse displays ubiquitin-positive intranuclear neuronal inclusions; implications for the cerebellar tremor/ataxia syndrome. Hum. Mol. Genet., 12, 949-959.
24. Tassone, F., Iwahashi, C. and Hagerman, P.J. (2004) FMR1 RNA within the intranuclear inclusions of fragile X-associated tremor/ataxia syndrome (FXTAS). RNA Biol., 1, 103-105.
25. Arocena, D.G., Iwahashi, C.K., Won, N., Beilina, A., Ludwig, A.L., Tassone, F., Schwartz, P.H. and Hagerman, P.J. (2005) Induction of inclusion formation and disruption of lamin A/C structure by premutation CGG-repeat RNA in human cultured neural cells. Hum. Mol. Genet., 14, 3661-3671.
26. Jin, P., Duan, R., Qurashi, A., Qin, Y., Tian, D., Rosser, T.C., Liu, H., Feng, Y. and Warren, S.T. (2007) Pur alpha binds to rCGG repeats and modulates repeat-mediated neurodegeneration in a Drosophila model of fragile X tremor/ataxia syndrome. Neuron, 55, 556-564.
27. Sofola, O.A., Jin, P., Qin, Y., Duan, R., Liu, H., de Haro, M., Nelson, D.L. and Botas, J. (2007) RNA-binding proteins hnRNP A2/B1 and CUGBP1 suppress fragile X CGG premutation repeat-induced neurodegeneration in a Drosophila model of FXTAS. Neuron, 55, 565-571.
28. Peier, A.M. and Nelson, D.L. (2002) Instability of a premutation-sized CGG repeat in FMR1 YAC transgenic mice. Genomics, 80, 423-432.
29. Pedersen, T. and Peters, H. (1968) Proposal for a classification of oocytes and follicles in the mouse ovary. J. Reprod. Fertil., 17, 555-557.
30. Gupta, S., Ramjaun, A.R., Haiko, P., Wang, Y., Warne, P.H., Nicke, B., Nye, E., Stamp, G., Alitalo, K. and Downward, J. (2007) Binding of ras to phosphoinositide 3-kinase p110alpha is required for ras-driven tumorigenesis in mice. Cell, 129, 957-968.
31. Gonzalez-Robayna, I.J., Falender, A.E., Ochsner, S., Firestone, G.L. and Richards, J.S. (2000) Follicle-Stimulating hormone (FSH) stimulates phosphorylation and activation of protein kinase B (PKB/Akt) and serum and glucocorticoid-lnduced kinase (Sgk): evidence for A kinase-independent signaling by FSH in granulosa cells. Mol. Endocrinol., 14, 1283-1300.
32. Alam, H., Maizels, E.T., Park, Y., Ghaey, S., Feiger, Z.J., Chandel, N.S. and Hunzicker-Dunn, M. (2004) Follicle-stimulating hormone activation of hypoxia-inducible factor-1 by the phosphatidylinositol 3-kinase/AKT/ Ras homolog enriched in brain (Rheb)/mammalian target of rapamycin (mTOR) pathway is necessary for induction of select protein markers of follicular differentiation. J. Biol. Chem., 279, 19431-19440.
33. Brown, C., LaRocca, J., Pietruska, J., Ota, M., Anderson, L., Smith, S.D., Weston, P., Rasoulpour, T. and Hixon, M.L. (2010) Subfertility caused by altered follicular development and oocyte growth in female mice lacking PKB alpha/Akt1. Biol. Reprod., 82, 246-256.
34. Fan, H.Y., Liu, Z., Cahill, N. and Richards, J.S. (2008) Targeted disruption of Pten in ovarian granulosa cells enhances ovulation and extends the life span of luteal cells. Mol. Endocrinol., 22, 2128-2140.
35. Yaba, A., Bianchi, V., Borini, A. and Johnson, J. (2008) A putative mitotic checkpoint dependent on mTOR function controls cell proliferation and survival in ovarian granulosa cells. Reprod. Sci., 15, 128-138.
36. Hoffman, G.E., Le, W.W., Entezam, A., Otauka, N., Tong, Z.B., Nelson, L., Flaws, J.A., McDonald, J.H., Jafar, S. and Usdin, K. (2012) Ovarian abnormalities in a mouse model of Fragile X primary ovarian insufficiency. J. Histochem. Cytochem., 60, 439-456.